Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Free Dating
Ñompany Maksim-LLC. Ýëåêòðîïðèâîäû. Made and sell.
Popular Articles

China Sky One Medical, Inc. Obtains SFDA Approval For Diclofenac Sodium Eye Drops
China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People"s Republic of China ("PRC"), announced that it obtained approval from the State Food and Drug Administration (SFDA) in China for the production of Diclofenac Sodium eye drops. The document number for the drug is 2009S02063.
new payday loan lenders
CDC Reports 21,449 Cases Of Swine Flu, Including 87 Deaths In The USA
The Centers for Disease Control and Prevention (CDC), USA, in its latest update, dated Friday evening, 19th June, 2009, reports a total of 21,449 confirmed human cases of swine flu A(H1N1) infection, including 87 deaths. Authorities say the novel A(H1N1) influenza virus has not mutated and is not more virulent (aggressive) than most normal seasonal human flu viruses. However, health services are bracing themselves for a busy flu season this winter as the swine flu virus will have been circulating for several months, but will still be a relatively novel one.
News of the day
One-year Phase III Study Confirms Ilaris(R) Offers Long-term Remission In Patients With CAPS, A Severe Lifelong Auto-inflammatory Disease
New results from a one-year Phase III study have confirmed that the investigational biological therapy Ilaris® (canakinumab, formerly ACZ885)[1] produced rapid and sustained remission of symptoms in the majority of children and adults with a rare and potentially life-threatening auto-inflammatory disease called cryopyrin-associated periodic syndrome (CAPS)1,2,3.
Public Health

NEJM Perspective Provides Overview Of Recent Health Reform Action

"Building Momentum as Democrats Forge Health Care Reform," New England Journal of Medicine: In a perspective piece, John Iglehart, a national correspondent for NEJM, reviews recent action on health reform. He discusses industry and provider groups" pledge to reduce spending by $2 trillion over the next 10 years, noting that the groups" pledge was a "recognition that the pace of reform is quickening and they wanted to be a full participant in negotiations." He also addresses congressional action, including discussions of a public insurance option and how lawmakers are attempting to address the cost of reform (Iglehart, NEJM, 5/14). Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009